Rockin Robin SongFlying The Web For News.
RobinPost Logo Amazon Prime Deals





Globe NewsWire News Distribution Service


Chicago, June 18, 2019 (GLOBE NEWSWIRE) -- Prevent Child Abuse America (PCA America) announced today that after a nationwide search its board of directors has selected Dr. Melissa Merrick as the organization's next president and chief executive officer. Merrick brings more than 18 years of clinical, research and leadership experience related to the etiology, course and prevention of child abuse and neglect. Merrick currently serves as a senior epidemiologist at the National Center for Injury Prevention and Control (NCIPC) at the Centers for Disease Control and Prevention (CDC) and will begin with PCA America on July 15.

"We’re pleased to have found an individual so uniquely qualified to assume leadership of the nation’s oldest and largest nonprofit organization focused on the primary prevention of child abuse and neglect," said PCA America Board Chair Andrea Robertson. “Dr. Merrick has strategically framed the prevention of early adversity as an urgent public health need, directly connected to positive child welfare, social and economic outcomes in her work at CDC. We’re thrilled she’ll be leading the next chapter of PCA America’s important work.”

“PCA America’s dedication to abuse and neglect prevention through the promotion of safe, stable, nurturing relationships and environments for all children and its network of state chapters can propel true data-driven prevention action,” explained Merrick. “This infrastructure and the organization’s evidence-based approach are among the critical factors that will advance the next generation of prevention work and ensure the conditions for strong and thriving children, families and communities across the country. I’m eager to begin this exciting new journey.”

Merrick will succeed Dan Duffy, a former two-term Illinois state senator and entrepreneur, who has led PCA America since 2016, a period of successful growth and change for the organization. Duffy announced in January that he would transition out of the chief executive role to start a government affairs consulting firm focused on strengthening American families.

“Dr. Merrick’s scientific and content expertise, strong relationships and partnerships and national leadership in the public health approach to prevention position her well to increase PCA America’s visibility and impact in the years to come,” according to Duffy. “I look forward to continuing to work with her and all of the organization’s talented and dedicated staff on behalf of our nation’s children and families.”

Merrick received her BA in psychology from the University of Pennsylvania and her master’s and doctoral degrees from San Diego State University/University of California, San Diego. Merrick also completed two years of postdoctoral training at the University of Miami, Miller School of Medicine’s Child Protection Team before joining CDC nine years ago. Merrick is married and has two young children who keep her grounded, thankful and hopeful for a brighter future for all children.

About Prevent Child Abuse America

Founded in 1972, Prevent Child Abuse America is a national organization with chapters in 48 states and nearly 600 Healthy Families America home visiting sites throughout the country. It promotes services that improve child well-being and develops programs that help to prevent all types of abuse and neglect. Additionally, Prevent Child Abuse America is rated as one of the top charities for children by Consumer Reports and numerous charity oversight organizations, including Charity Navigator, GreatNonprofits and GuideStar.

Charles Mutscheller
Prevent Child Abuse America
312-663-3520
This email address is being protected from spambots. You need JavaScript enabled to view it.


Posted: 2019-06-18 15:07:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



More News From This Category
Press Release: Gluten-free Baking Mixes Market Nears $1 Billion by 2033 - Demand for Gluten-Free Baking Mixes Rises with Health-conscious Trends
Wed, 07 Jan 2026 17:07:47 +0000

Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "Gluten-free Baking Mixes Market Report by Product Type, Flour Type, Distribution Channel, Countries and Company Analysis, 2025-2033" has been added to ResearchAndMarkets.com's offering.

Read More ...


Press Release: CORRECTION -- Emerita Resources Corp.
Wed, 07 Jan 2026 14:07:44 +0000

TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- In a release issued earlier today by Emerita Resources Corp. (TSX-V: EMO; OTCQB: EMOTF; FSE: LLJA), please note that a typo in the headline has been corrected — “12.1m Grading” instead of “2.1m Grading.” The corrected release follows:

Read More ...


Press Release: On 7 January 2026, Freudenberg Home and Cleaning Solutions GmbH announced a recommended public offer to the shareholders of Nilfisk Holding A/S to tender all outstanding shares in Nilfisk to Freudenberg
Wed, 07 Jan 2026 11:07:44 +0000

COPENHAGEN, Denmark, Jan. 07, 2026 (GLOBE NEWSWIRE) -- On 7 January 2026, Freudenberg Home and Cleaning Solutions GmbH (“Freudenberg”) announced a recommended public offer to the shareholders of Nilfisk Holding A/S (“Nilfisk” or the “Company”) to tender all outstanding shares in Nilfisk to Freudenberg at a price of DKK 140 for each share of nominally…

Read More ...


Press Release: World-renowned Immunologist and Distinguished Scientist Joins CancerVax as Senior Scientific Advisor
Wed, 07 Jan 2026 08:07:41 +0000

Lehi Utah, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Lehi, Utah, January 7, 2026 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that Mark M. Davis, PhD will serve as the Company’s Senior Scientific Advisor.

Read More ...


Press Release: Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering
Wed, 07 Jan 2026 05:07:43 +0000

BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced the pricing of its underwritten public offering of 2,212,000 shares of its common stock at a public…

Read More ...


Related Bing News Results
ME Group Completes Pre-A Extension Round and Acquires Video Production and Distribution Platform BTV
Tue, 06 Jan 2026 06:08:00 GMT
ME Group, a leading Web3 media and brand growth services institution, announced that it has secured strategic investments from FutureMoney Group and Bit Origin (Nasdaq: BTOG).

Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
Wed, 03 Dec 2025 13:09:00 GMT
TORONTO, Jan. 06, 2026 (GLOBE NEWSWIRE) -- (TSX: SPFD) Mulvihill Enhanced Split Preferred Share ETF has declared a monthly cash distribution in the amount of $0.08333 per unit, payable on February 6, ...














Blow Us A Whistle


Related Product Search/Búsqueda de productos relacionados

Amazon Logo